Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine vs curcumin vs leuprolide for uterine leiomyoma volume reduction
IRCT20220201053908N1Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Fibromyoma (LM) comparing Berberine arm, Curcumin arm and Leuprolide arm (3 arms). Primary endpoints: Uterine myoma size, Luteinizing hormone and 2 more. Started Mar 2022; status: completed.
02
Drugs
berberinecurcuminleuprolide
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20220201053908N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220201053908N1.